AI and GxP Readiness Assessment
Before adopting AI in a regulated environment, organizations need to understand the intended use, associated risks, required controls, and expected business value.
CliniGene evaluates your current and proposed AI use across Quality, Clinical, Regulatory, Manufacturing, and supporting technology processes.
Services Include
- AI-use and shadow-AI inventory
- Workflow and data assessment
- GxP-impact determination
- AI risk classification
- Data privacy and security review
- Vendor documentation review
- Governance gap assessment
- Use-case prioritization
- Validation recommendations
- 90-day implementation roadmap